Intimation of Appointment of CFO Pursuant to Regulation 30 of SEBI(LODR) Regulation 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has appointed Mr. Chintan Didawala Ganpat as its new Chief Financial Officer, effective May 6, 2025. The appointment was made by the Board based on the recommendation of the Nomination & Remuneration Committee. The change was needed to fill a casual vacancy created by the resignation of the previous CFO. Mr. Chintan brings experience in finance and management and currently holds no shares in the company.
While appointing a new CFO is a routine governance update, the underlying signal is that the previous CFO resigned mid-term, which shareholders may want to monitor for any deeper reasons behind the departure.